SECTOR ROUND-UP
At the FOMC meeting on 16 March 2022, the Fed rate was raised by 25bps from 0-0.25% to 0.25-0.5%. The median member of the FOMC expects the Fed fund rate to be 1.9% at end of the year, a total of seven rate hikes in 2022. Looking back at past rate hike cycles in 2013, 2015 and 2017 (Figure 3), we observe a strong inverse correlation between the 2Y-10Y yield curve and the price performance of the SREIT. SREITs have outperformed when yield spreads narrow. We think SREITs could rally, considering 2022-23 rate hike expectations and yield spread compression.
While rising interest rates are a headwind for REITs, SREITs have employed a high interest rate hedge averaging c.72%. Based on sensitivity analysis of SREITs under our coverage (Figure 4), a 100bps increase in interest rates will reduce FY22 DPUs by 0.7-8.6% and 3.7-15.4% on a hedged and unhedged basis, while a 50bps increase in our DDM risk-free rate assumption will reduce our target prices by 0.3-5.0%.
Retail
Singapore announced further relaxation of COVID restrictions on 24 March 2022; (1) raising of dine-in and group size from five to 10; (2) resumption of atrium sales; (3) capacity limits raised to 1,000 pax or 75% of venue capacity; (4) sale of alcohol permitted after 10:30pm; and (5) workplace capacity increased from 50% to 70%. Return to office and larger dine-in group sizes should help draw more footfall to malls and uplift tenant sales for both suburban and downtown malls. The Jan22 retail and F&B sales have recovered, coming in 1.8% and 5.9% below Jan19 levels (Figure 10 and 11).
Hospitality
Quarantine-free entry into Singapore for vaccinated travellers will begin on 1 April 2022. Vaccinated travellers are subjected only to a pre-departure test. The removal of quarantine and VTL-designated flight requirements and reduction of COVID-testing requirements is a big step towards rebooting Singapore’s tourism industry. However, we expect the number of hotels booked by the government for isolation purposes, which has benefitted some of the hospitality SREITs, to taper off.
Resident outbound by air outpaced international visitor arrival (IVA) at 11.7% and 4.3% of 2019’s monthly average respectively. Feb22 RevPAR was up 76.8% due to higher occupancy and room rates. Feb22 occupancy was 62.4%, up from 44.7% a year ago, but still 26ppts below Feb19’s 88.5%.
INVESTMENT RECOMMENDATION
Maintain OVERWEIGHT on SREITs
SREITs have exhibited an inverse correlation with the yield curve, with periods of narrowing yield spread often corresponding with a rally in share prices. We could see REITs rally, supported by recovery of retail, office and hospitality REITs as the world returns to normalcy. The raising of interest rates is intended to keep inflation and growth in check. This may result in a reversal of flows back into REITs as growth stocks looks less attractive on a risk adjusted basis.
Bloomberg consensus forecasts 2022/23 10YSGS yields at 2.0% and 2.3% respectively. We remain overweight on SREITs due to the high levels of interest rate hedging employed, averaging 72%, and portfolio rebalancing and rejuvenation efforts by the REITs during the pandemic years. REITs made $13bn in acquisitions in 2021, entering this phase of recovery with even stronger balance sheets.
Sub-sector preferences: Industrial and Retail
We believe the industrial sub-sector will be resilient, delivering DPU growth on the back of AEIs and acquisitions. Industrial REITs have been the most active in acquisitions, owing to an early recovery in their share prices. Retail will benefit from the return to normalcy and pickup in social activity post-relaxation of COVID restrictions which will help lift tenant sales and sentiment.
Retail (OVERWEIGHT). Retail occupancy hit a 10-year low in 2020 but has since rebounded to 92% and we are starting to see rents bottom out. Reversions for suburban malls are starting to turn positive while negative reversions for downtown malls are narrowing. There is also very little new supply hitting the market. Return to office and a pick-up in social activities should help lift tenant sales and return confidence back to retailers. We are overweight on the sector, especially suburban malls, which despite their resilience during the pandemic, are still trading 15% below pandemic levels.
Office (NEUTRAL). The office market is showing signs of recovery. Core CBD rents posted three consecutive quarters of growth, although occupancy at 88% is still 2ppts below the 5-year average. We are neutral on the office sector as supply is slightly elevated. The 3-year average supply of 1mn sq ft p.a is above historical 5- and 10-year averages. While return to office should allow occupiers to better evaluate their space need and result in more decisive renewal discussions, we are cautious that more downsizing could occur, leading to oversupply in the near term.
Industrial (OVERWEIGHT). Rents have bottomed out after declining for 7 years while occupancy has recovered back to 2016 levels due to better occupancy at factories and warehouses. Industrial REITs benefit from the secular growth of new economy tenants such as tech, life sciences, biomedical, semi-con and electronics manufacturing, which typically locate themselves in high-spec, science and business parks and warehouses. We are also seeing structural shifts, such as e-commerce and manufacturers moving from just-in-time inventory management to just-in-case in view of supply chain disruptions.
Hospitality (NEUTRAL). Feb22 revenue per available room (RevPAR) jumped 77% YoY on the back of higher occupancy and average daily rates, but was still 41% below 2019 levels. The hospitality sector faces a long road to recovery. We estimate that the industry may only return to pre-COVID levels in 2024, in line with the World Tourism Organisation forecast. DPU yields are expected to be depressed as DPUs recover over the next two years. While we expect more price recovery for hospitality REITs, in view of recent share price appreciation, we see more upside for retail and industrial SREITs.
Important Information
This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.
By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.
The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.
Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.
Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.
To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.
This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.
This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.
IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE
Where the report contains research analyses or reports from a foreign research house, please note:
